← Evidence map

ArticleAlimentary pharmacology & therapeutics2026

Editorial: Rifaximin and the Gut-Liver-Brain Axis-Progress and Prudence. Authors' Reply.

Hiroki Inada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42438271